Literature DB >> 16265621

Integrating care for hepatitis C virus (HCV) and primary care for HIV for injection drug users coinfected with HIV and HCV.

Thomas F Kresina1, R Douglas Bruce, Victoria A Cargill, Laura W Cheever.   

Abstract

Injection drug use accounts for most of the incident infections with hepatitis C virus (HCV) and for at least one-third of new human immunodeficiency virus (HIV) infections. Coinfection with HCV and HIV presents complex and challenging medical conditions. Ensuring access to and maintaining care for HIV and HCV for drug users presents special challenges to the health care team that require a nonjudgmental attitude, experience, and patience. Care for HCV infection, however, can be used as an instrument to engage drug-using persons in ongoing primary care relationships. Common elements to both care for HCV infection and primary care for HIV infection are testing for and counseling about HCV and HIV, substance abuse and mental health services, social support, and subspecialty referral. These elements, in particular treatment for substance abuse, can be focal points for model care systems that provide integrative care for both HCV and HIV infections.

Entities:  

Mesh:

Year:  2005        PMID: 16265621     DOI: 10.1086/429502

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  12 in total

Review 1.  Structural interventions: concepts, challenges and opportunities for research.

Authors:  K M Blankenship; S R Friedman; S Dworkin; J E Mantell
Journal:  J Urban Health       Date:  2006-01       Impact factor: 3.671

Review 2.  Hepatitis infection in the treatment of opioid dependence and abuse.

Authors:  Thomas F Kresina; Diana Sylvestre; Leonard Seeff; Alain H Litwin; Kenneth Hoffman; Robert Lubran; H Westley Clark
Journal:  Subst Abuse       Date:  2008-04-28

3.  Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial.

Authors:  Sunil Suhas Solomon; Thomas C Quinn; Suniti Solomon; Allison M McFall; Aylur K Srikrishnan; Vinita Verma; Muniratnam S Kumar; Oliver Laeyendecker; David D Celentano; Syed H Iqbal; Santhanam Anand; Canjeevaram K Vasudevan; Shanmugam Saravanan; David L Thomas; Kuldeep Singh Sachdeva; Gregory M Lucas; Shruti H Mehta
Journal:  J Hepatol       Date:  2019-10-08       Impact factor: 25.083

Review 4.  Psychiatric behavioral aspects of comanagement of hepatitis C virus and HIV.

Authors:  Jeffrey J Weiss; Jack M Gorman
Journal:  Curr HIV/AIDS Rep       Date:  2006-11       Impact factor: 5.071

5.  Physical and Mental Health Comorbidities Associated With Primary Care Visits For Substance Use Disorders.

Authors:  Pooja A Lagisetty; Donovan Maust; Michele Heisler; Amy Bohnert
Journal:  J Addict Med       Date:  2017 Mar/Apr       Impact factor: 3.702

6.  A window of opportunity: maximizing the effectiveness of new HCV regimens in the United States with the expansion of the Affordable Care Act.

Authors:  Sean J Haley; Mary Jeanne Kreek
Journal:  Am J Public Health       Date:  2015-01-20       Impact factor: 9.308

7.  Barriers to hepatitis C virus treatment in a Canadian HIV-hepatitis C virus coinfection tertiary care clinic.

Authors:  M McLaren; G Garber; C Cooper
Journal:  Can J Gastroenterol       Date:  2008-02       Impact factor: 3.522

Review 8.  Hepatitis C Virus Elimination in the Human Immunodeficiency Virus-Coinfected Population: Leveraging the Existing Human Immunodeficiency Virus Infrastructure.

Authors:  Meredith E Clement; Lauren F Collins; Julius M Wilder; Michael Mugavero; Taryn Barker; Susanna Naggie
Journal:  Infect Dis Clin North Am       Date:  2018-06       Impact factor: 5.982

9.  Spillover effects of HIV testing policies: changes in HIV testing guidelines and HCV testing practices in drug treatment programs in the United States.

Authors:  Jemima A Frimpong; Thomas D'Aunno; Stéphane Helleringer; Lisa R Metsch
Journal:  BMC Public Health       Date:  2016-07-29       Impact factor: 3.295

10.  The hepatitis C cascade of care among HIV infected patients: a call to address ongoing barriers to care.

Authors:  Edward R Cachay; Lucas Hill; David Wyles; Bradford Colwell; Craig Ballard; Francesca Torriani; William C Mathews
Journal:  PLoS One       Date:  2014-07-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.